BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Matsuno Y, Hirano A, Torisu T, Okamoto Y, Fuyuno Y, Fujioka S, Umeno J, Moriyama T, Nagai S, Hori Y, Fujiwara M, Kitazono T, Esaki M. Short-term and long-term outcomes of indigo naturalis treatment for inflammatory bowel disease. J Gastroenterol Hepatol 2020;35:412-7. [PMID: 31389626 DOI: 10.1111/jgh.14823] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 2.3] [Reference Citation Analysis]
Number Citing Articles
1 Tischler D, Kumpf A, Eggerichs D, Heine T. Styrene monooxygenases, indole monooxygenases and related flavoproteins applied in bioremediation and biocatalysis. Flavin-Dependent Enzymes: Mechanisms, Structures and Applications. Elsevier; 2020. pp. 399-425. [DOI: 10.1016/bs.enz.2020.05.011] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.5] [Reference Citation Analysis]
2 Sun Q, Leng J, Tang L, Wang L, Fu C. A Comprehensive Review of the Chemistry, Pharmacokinetics, Pharmacology, Clinical Applications, Adverse Events, and Quality Control of Indigo Naturalis. Front Pharmacol 2021;12:664022. [PMID: 34135755 DOI: 10.3389/fphar.2021.664022] [Reference Citation Analysis]
3 Yang QY, Ma LL, Zhang C, Lin JZ, Han L, He YN, Xie CG. Exploring the Mechanism of Indigo Naturalis in the Treatment of Ulcerative Colitis Based on TLR4/MyD88/NF-κB Signaling Pathway and Gut Microbiota. Front Pharmacol 2021;12:674416. [PMID: 34366843 DOI: 10.3389/fphar.2021.674416] [Reference Citation Analysis]
4 Uchiyama K, Takami S, Suzuki H, Umeki K, Mochizuki S, Kakinoki N, Iwamoto J, Hoshino Y, Omori J, Fujimori S, Yanaka A, Mizokami Y, Ohkusa T. Efficacy and safety of short-term therapy with indigo naturalis for ulcerative colitis: An investigator-initiated multicenter double-blind clinical trial. PLoS One 2020;15:e0241337. [PMID: 33151988 DOI: 10.1371/journal.pone.0241337] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
5 Yu T, Li Z, Xu L, Yang M, Zhou X. Anti-inflammation effect of Qingchang suppository in ulcerative colitis through JAK2/STAT3 signaling pathway in vitro and in vivo. J Ethnopharmacol 2021;266:113442. [PMID: 33027643 DOI: 10.1016/j.jep.2020.113442] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
6 Saiki JP, Andreasson JO, Grimes KV, Frumkin LR, Sanjines E, Davidson MG, Park KT, Limketkai B. Treatment-refractory ulcerative colitis responsive to indigo naturalis. BMJ Open Gastroenterol 2021;8:e000813. [PMID: 34969665 DOI: 10.1136/bmjgast-2021-000813] [Reference Citation Analysis]
7 Liang YN, Yu JG, Zhang DB, Zhang Z, Ren LL, Li LH, Wang Z, Tang ZS. Indigo Naturalis Ameliorates Dextran Sulfate Sodium-Induced Colitis in Mice by Modulating the Intestinal Microbiota Community. Molecules. 2019;24. [PMID: 31726738 DOI: 10.3390/molecules24224086] [Cited by in Crossref: 15] [Cited by in F6Publishing: 12] [Article Influence: 5.0] [Reference Citation Analysis]
8 Qi-Yue Y, Ting Z, Ya-Nan H, Sheng-Jie H, Xuan D, Li H, Chun-Guang X. From natural dye to herbal medicine: a systematic review of chemical constituents, pharmacological effects and clinical applications of indigo naturalis. Chin Med 2020;15:127. [PMID: 33317592 DOI: 10.1186/s13020-020-00406-x] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]